Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study

2016151 citationsJournal Articlehybrid Open Access

Authors

Ralf Gold · Ruhr University Bochum

Douglas L. Arnold · NeuroRx Research (Canada)

Amit Bar‐Or · McGill University

Michael Hutchinson · St. Vincent's University Hospital

Ludwig Kappos · University Hospital of Basel

Eva Havrdová · Charles University

David MacManus ·

Abstract

Treatment with DMF was associated with continuously low clinical and magnetic resonance imaging (MRI) disease activity in patients with RRMS. These interim data demonstrate a sustained treatment benefit and an acceptable safety profile with DMF.

Topics & Keywords

Multiple Sclerosis Research Studies Polyomavirus and related diseases Fungal Plant Pathogen Control

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Multiple Sclerosis Journal

Volume 23, Issue 2, pp. 253-265

DOI: 10.1177/1352458516649037

Field-Weighted Citation Impact: 14.75